Cystic Fibrosis (CF) Therapeutics Market Trend Shows a Rapid Growth by 2030 According to New Research Report

Cystic Fibrosis Therapeutics Market: Overview

Identifying targets that cause cystic fibrosis, a type of autosomal recessive disease, has led to the broadening of candidates in the cystic fibrosis (CF) therapeutics market. Per the Cystic fibrosis foundation patient registry: annual data report to the center directors, 2014, CF has at least 70,000 cases worldwide and ~ 1000 new cases are added each year.

Read Report Overview –

This paints a grim picture and an unmet need in worldwide populations. The CF therapeutics market is thus making strides on the back of growing body of clinical studies that expand the understanding of pathophysiology.

Perhaps the most extensively researched category is Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulators. Some of the other therapeutics in the cystic fibrosis (CF) therapeutics market are bronchodilators drugs, mucolytic drugs, anti-infective, antibiotics, antiinflammatory drugs, and pancreatic enzyme supplements.

Request Brochure of Report –

Cystic Fibrosis Therapeutics Market: Key Trends

The key driver for cystic fibrosis therapeutics market is the steadily expanding drug pipelines. Score of drug candidates are present in the pipeline and more are being added each year. Growing research interest in small-molecule drugs targeting the protein mutated in CF has been boosting the market. Growing number of clinical trials is boosting the prospect in the CF therapeutics market. PTI-428, QR-010, AZD-5634, and POL-6014 are some of the key drugs spurring research investments in the market.

Growing number of people with lung problems is a key trend boosting the market. Over the years, extensive studies have been made in the category CFTR modulators. Recent years have seen some of the exciting product developments in this regard.

Pre Book Cystic Fibrosis Therapeutics Market Report at

Cystic Fibrosis Therapeutics Market: Key Developments

A growing number of players have consolidated their shares in the CF therapeutics market are focused on developing oral routes of administration. Growing popularity of oral drugs due to the ease of administration is also attracting research interest. Further, CFTR modulators are increasing in clinical relevance in all demographics.

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453